Results 191 to 200 of about 419,034 (232)
Some of the next articles are maybe not open access.

Mitochondrial DNA polymorphism in mitochondrial myopathy

Human Genetics, 1988
In order to test the hypothesis that mitochondrial myopathy may be caused by mutation of the mitochondrial (mt) genome, restriction fragment length polymorphism in leucocyte mt DNA has been studied in 38 patients with mitochondrial myopathy, 44 of their unaffected matrilineal relatives, and 35 normal control subjects.
I J, Holt   +2 more
openaire   +2 more sources

Familial Mitochondrial Myopathies

1981
Mitochondrial myoencephalopathies might be defined as diseases with mitochondrial alterations in skeletal muscle and brain, often combined with mitochondrial alterations in other organs. Examples are Reye’s syndrome (8, 9) kinky hair syndrome (3, 4) and Zellweger’s syndrome (5, 6).
G F, Walter, S, Tassin, J M, Brucher
openaire   +2 more sources

Mitochondrial and Metabolic Myopathies

Continuum, 2019
This article provides an overview of mitochondrial and metabolic biology, the genetic mechanisms causing mitochondrial diseases, the clinical features of mitochondrial diseases, lipid myopathies, and glycogen storage diseases, all with a focus on those syndromes and diseases associated with myopathy.
openaire   +2 more sources

Updates on Mitochondrial Myopathies

Current Neurology and Neuroscience Reports
Mitochondrial myopathies (MM) are a genetically and clinically heterogeneous group of disorders that remain underrecognized in adult and pediatric neurology. This review aims to provide a clinically useful tool for guiding diagnosis and management of MM.
Emanuele, Barca, Valentina, Emmanuele
openaire   +2 more sources

Metabolic and mitochondrial myopathies

Current Opinion in Rheumatology, 1989
Metabolic myopathies are the result of genetic defects that cause disordered energy metabolism. These diseases can cause a variety of myopathic syndromes and can become clinically manifest at any age. Recent advances in the understanding of the molecular and metabolic bases for these diseases have resulted in expanded clinical descriptions, recognition
openaire   +3 more sources

MITOCHONDRIAL MYOPATHY DIAGNOSIS

Neurologic Clinics, 2000
Oxidative phosphorylation (OXPHOS) accounts for approximately 95% of the adenosine triphosphate (ATP) produced by the cell. The central nervous system, peripheral nervous system, cardiac muscle, skeletal muscle, and smooth muscle are highly susceptible to dysfunction of this complex enzyme system. Although most OXPHOS diseases are multisystem disorders,
openaire   +2 more sources

Mitochondrial Myopathy

American Journal of Clinical Pathology, 1969
E R, Fisher, T S, Danowski
openaire   +2 more sources

Mitochondrial Myopathies

Biochemical Society Transactions, 1979
J M, Land, J B, Clark
openaire   +2 more sources

More on Mitochondrial Myopathies

Anesthesia & Analgesia, 2016
Veyckemans, Francis   +2 more
openaire   +3 more sources

Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy

Cell Metabolism, 2020
Virginia Brilhante   +2 more
exaly  

Home - About - Disclaimer - Privacy